(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
Robert Oberlender, D E Nichols
Journal of Pharmacology and Experimental Therapeutics December 1, 1990 DOI: 10.1016/s0022-3565(25)22947-0 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Drug discrimination study in rats Peer reviewed |
|---|---|
| Population | Rats trained to discriminate saline from (+)-MBDB |
| Interventions | MDMA 3 (+)-lysergic acid diethylamide 2 5-dimethoxy-4-methylamphetamine mescaline (+)-amphetamine (+)-methamphetamine cocaine 5 6-methylenedioxy-2-aminoindan |
| Dose | 7.18 mumol/kg (1.75 mg/kg) (+)-MBDB hydrochloride |
| Keywords | Animals Rats, inbred strains N-methyl-3,4-methylenedioxyamphetamine Indans Hallucinogens Behavior, animal Learning Dose-response relationship, drug Stereoisomerism Male |
| Key points | The (+)-MBDB discriminative cue generalized to MDMA and MDA with similar stereoselectivity, but not to hallucinogens (LSD, DOM, mescaline) or psychostimulants (amphetamine, methamphetamine); cocaine produced partial substitution. The authors argue this supports a distinct "entactogen" drug class, and that non-neurotoxic MDA analogs (5,6-methylenedioxy-2-aminoindan and its N-methyl derivative) fully substituted for (+)-MBDB, indicating entactogen-like effects can be separated from neurotoxic potential. |
Abstract
The stimulus properties of 3,4-methylenedioxymethamphetamine (MDMA)-like compounds were studied in rats trained to discriminate saline from (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine [(+)-MBDB] hydrochloride (7.18 mumol/kg; 1.75 mg/kg), the alpha-ethyl homolog of MDMA. In previous experiments with (+)-MBDB as a test drug, complete substitution was observed for MDMA but not for (+)-lysergic acid diethylamide or (+)-amphetamine. In the study reported here, the (+)-MBDB cue generalized to MDMA and the parent drug, 3,4-methylenedioxyamphetamine. All three drugs exhibited a similar stereoselectivity, the (+)-isomer having potency greater than the (-)-isomer. By contrast, the hallucinogens, (+)-lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine and mescaline and the psychostimulants (+)-amphetamine and (+)-methamphetamine did not substitute for (+)-MBDB. Cocaine produced partial substitution. The results support the hypothesis that the primary behavioral activity of MDMA-like compounds is unlike that of hallucinogens and stimulants and may represent the effects of a novel drug class, given the name entactogens. Although the mechanism of action for the discriminative stimulus properties of MDMA-like compounds is not known, there is evidence that presynaptic serotonergic, but not dopaminergic, mechanisms are critical. Finally, 5,6-methylenedioxy-2-aminoindan a non-neurotoxic 3,4-methylenedioxyamphetamine rigid analog that was previously found to substitute for MDMA but not for (+)-lysergic acid diethylamide was found in the study described here to substitute completely for (+)-MBDB. The N-methyl derivative 5,6-methylenedioxy-2-methylminoindan produced similar results. The demonstration of entactogen-like discriminative stimulus properties, for drugs devoid of neuronal degenerative toxicity potential, serves as evidence of the independent mechanisms for these effects in rats.
Citations in the library
Cited by 31
- 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans Addiction May 1, 1994
- Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups Journal of Medicinal Chemistry 1996
- Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives Journal of Medicinal Chemistry September 1, 1997
- Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated Frontiers in Psychiatry March 25, 2022
- Thieno[3,2-b]- and Thieno[2,3-b]pyrrole Bioisosteric Analogues of the Hallucinogen and Serotonin Agonist N,N-Dimethyltryptamine Journal of Medicinal Chemistry March 1, 1999
and 26 more in the library